Skip to main content

Find Clinical Trials

Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,014 public trials 531 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome

NCT01075425

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

T-Cell Depletion in Unrelated Donor Marrow Transplantation

NCT00000591

Conditions: Bone Marrow Diseases, Bone Marrow Transplantation, Graft vs Host Disease, +8 more
Locations: Not specified

View Trial Details

Completed

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

NCT01360125

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Completed

Cord Blood Stem Cell Transplantation Study (COBLT)

NCT00000603

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +21 more
Locations: Not specified

View Trial Details

Completed

Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib

NCT02733445

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

NCT01275196

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Wuhan, Hubei, China

Novartis Investigative Site Chengdu, Sichuan, China

View Trial Details

Completed

Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response

NCT01043874

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia in Chronic Phase, +12 more
Locations: Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Aomori, Japan

View all 20 locations

View Trial Details

Completed

An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome

NCT01751867

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Beijing, China

Chengdu, China

Guangdong, China

Hangzhou, China

View Trial Details

Completed

Effect of Food on Bioavailability of Modified Release Formulations of Imatinib

NCT00420043

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Not specified

View Trial Details

Completed

Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib

NCT00422825

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Not specified

View Trial Details